Project Grant R01DA063599
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UC San Diego a $730,649 Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) effective May 1, 2026, through February 28, 2031, to conduct research on the acute effects of cannabis use on parenting behavior. The project will examine how cannabis consumption impacts parenting quality among 190 parents who use cannabis regularly (4+ days per week) and have children ages 3-6 years old. The research...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $165,669 Project Grant to the University of California, San Diego, effective August 1, 2026, through July 31, 2028, under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant funds research to identify behavioral and neural markers of opioid withdrawal-induced risk-taking and their relationship to relapse vulnerability. The project employs a translatable rodent model utilizing the Iowa...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $1.315 million Project Grant to the University of California, Irvine, effective September 1, 2025, through May 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research project delivers basic neuroscience research investigating the neural mechanisms underlying motivational and cognitive impairment during opioid withdrawal. The study will employ sophisticated behavioral...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $542,187 Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) to the Public Health Institute on June 15, 2026, for "Assessing the Role of Cannabis in Sober Living Houses," with completion targeted for March 31, 2031. This research initiative will generate empirical evidence and assessment tools addressing a critical gap in understanding cannabis use among individuals in recovery...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant totaling $187,777 to the University of California, San Diego, effective September 1, 2025, through August 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research initiative will examine the interactive effects of caffeine and cannabis use on neurocognitive outcomes in adolescents and young adults. The project addresses a critical gap in longitudinal research...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the Research Foundation For Mental Hygiene, Inc. (operating through the New York State Psychiatric Institute) a Project Grant totaling $195,804 under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period August 1, 2026 through July 31, 2031. This research project investigates the effects of cannabis on nicotine use patterns, specifically examining how cannabis influences electronic nicotine...
- This $109,076 Project Grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research examining the relationship between ovarian steroid hormones and cannabis use patterns in reproductive-aged females. The project, awarded to the University of Illinois on January 25, 2026, with completion anticipated by January 24, 2030, addresses a critical gap in understanding why females exhibit faster progression to Cannabis...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UC San Diego a $197,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2027. The award supports development and validation of an in vivo Massively Parallel Reporter Assay (MPRA) methodology to characterize the functional role of cis-regulatory elements and genetic variants associated with substance use disorders. Specifically, the...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $439,500 to the University of California, San Diego for a two-year project (March 1, 2026 – February 29, 2028) under the Drug Use and Addiction Research Programs (CFDA 93.279). This project will develop and validate a novel, real-time data collection paradigm for studying family dynamics and their relationship to adolescent substance use. The deliverables include creation of an episode-based assessment...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Southern California a Project Grant totaling $149,766 on August 12, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate simultaneous nicotine, alcohol, and cannabis co-use among young adults through May 15, 2029. This research deliverable addresses a significant gap in the existing literature by comprehensively examining patterns of multi-substance use...
The National Institute on Drug Abuse (NIDA) awarded a $734,188 Project Grant to the University of California, San Diego, effective July 15, 2026, through April 30, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research initiative investigates sex differences in cannabis withdrawal mechanisms and recovery of neuropsychological and behavioral functioning in emerging adults (ages 18-25) with heavy cannabis use. The project will recruit 220 participants balanced by sex, with 64% meeting criteria for heavy cannabis use, and conduct a 6-week monitored abstinence period. Deliverables include repeated toxicological and endocannabinoid (ECB) biomarker assessments, neuropsychological and behavioral evaluations, and twice-daily ecological momentary assessment data collection to characterize how sex-specific cannabinoid and ECB biomarkers predict withdrawal and recovery outcomes over time. The research addresses critical gaps in prior cannabis withdrawal studies by extending monitoring periods beyond cannabinoid detectability, incorporating objective biomarker measurement, and explicitly examining sex-specific effects—an important consideration given evidence that females are particularly vulnerable to cannabis effects and withdrawal symptoms due to sexually dimorphic characteristics of the endocannabinoid system. This investigation directly supports NIDA's research priorities in substance use prevention, diagnosis, and treatment development for emerging vulnerable populations undergoing significant neurodevelopmental changes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $734.2k | 7/10/26 |